News / Events Press Releases IR Calendar Audio and Video Email Alerts All News 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 Search terms Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use Jun 29, 2022 Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market Jun 14, 2022 Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher May 24, 2022 Pressure BioSciences, Inc. Reports Q1 2022 Financial Results May 19, 2022 Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program May 4, 2022 Pressure BioSciences to Present at the Planet MicroCap Showcase 2022 on May 4, 2022 May 3, 2022 Pressure BioSciences Announces Early Access Program for UST Nanoemulsion Processing Apr 27, 2022 Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference Apr 19, 2022 Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022 Apr 5, 2022 Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update Apr 1, 2022 1 2 3 4 5 6 7 8 9 10 ...42
Pressure BioSciences Announces Contracted Production Launch for Estimated $3,000,000 of UST-Processed, Nanoemulsified CBD Spray for Oral Use Jun 29, 2022
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market Jun 14, 2022
Emerging Technology Insider Releases New TechTalks Video Interview with Pressure BioSciences' CEO Richard T. Schumacher May 24, 2022
Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program May 4, 2022
Pressure BioSciences to Discuss Recent Achievements and Upcoming Commercialization of its Enabling UST Platform at the Sequire Cannabis & Psychedelics Conference Apr 19, 2022
Pressure BioSciences Leveraging Strong FY2021 Operational and Financial Successes, Worldwide Customer Base, Substantial IP Estate, and Three Powerful Technology Platforms to Accelerate Strategic Company Transformation in 2022 Apr 5, 2022
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2021 Financial Results and Provide Business Update Apr 1, 2022
